Xiaowen Tian

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Neuroendocrine Tumors

Prognostic Factors

Patient Reported Outcomes

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Zheng Xu, Lulu Guo, Jingjing Yu, Siyuan Shen, Chao Wu, Weifeng Zhang, Chang Zhao, Yue Deng, Xiaowen Tian, Yuying Feng, Hanlin Hou, Lantian Su, Hongshuang Wang, Shuo Guo, Heli Wang, Kexin Wang, Peipei Chen, Jie Zhao, Xiaoyu Zhang, Xihao Yong, Lin Cheng, Lunxu Liu, Sheng-Yong Yang, Fan Yang, Xiaohui Wang, Xiao Yu, Yun-Fei Xu, Jin-Peng Sun, Wei Yan, Zhenhua Shao
Ligand recognition and G protein coupling of trace amine receptor TAAR1. Nature (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)